IOVA Iovance Biotherapeutics, Inc. - Common Stock
Sobre Iovance Biotherapeutics, Inc. - Common Stock Visão geral da empresa da Wikipedia
Iovance Biotherapeutics, Inc. is a biopharmaceutical based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte (TIL) therapies against cancer.
Ler mais
Iovance Biotherapeutics, Inc. is a biopharmaceutical based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte (TIL) therapies against cancer.
## History
The company was founded in 2007 as Genesis Biopharma. In 2013, Lion merged with Genesis Biopharma аnd became Lion Bio Pharma, which was then rebranded to Iovance in 2017.
In 2024, the US FDA gave accelerated approval to Lifileucel, marketed under the brand name Amtagvi, the company's tumor-infiltrating lymphocyte drug for the treatment of unresectable or metastatic melanoma.
Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗
IOVA Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
IOVA Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
IOVA Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
- Compra forte 3 20,0%
- Compra 9 60,0%
- Manter 3 20,0%
- Venda 0 0,0%
- Venda forte 0 0,0%
Preço-alvo de 12 meses
9 analistas · 2026-08-19Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
| Período | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|
| 30 de Junho de 2026 | $-0.11 | $-0.13 | 0.02% |
| 31 de Março de 2026 | $-0.19 | $-0.15 | -0.04% |
| 31 de Dezembro de 2025 | $-0.18 | $-0.18 | -0.00% |
| 30 de Setembro de 2025 | $-0.25 | $-0.26 | 0.01% |
| 30 de Junho de 2025 | $-0.33 | $-0.29 | -0.04% |
| 31 de Março de 2025 | $-0.36 | $-0.24 | -0.12% |
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| IOVA | $1.12B | -2.5 | 60.6% | -148.4% | -56.0% | — |
| IDYA | $3.04B | -27.0 | 3024.4% | -52.0% | -11.5% | — |
| CLDX | $1.81B | -7.0 | -78.0% | -16748.0% | -43.8% | — |
| ARQT | $3.58B | -223.4 | 91.3% | -4.3% | -9.8% | — |
| GRAL | $3.45B | -7.7 | 17.2% | -277.5% | -16.7% | — |
| IMNM | $2.43B | -8.8 | -23.2% | -3060.0% | -47.0% | — |
| IRON | $3.01B | -13.2 | — | — | -31.3% | — |
| NRIX | $1.80B | -5.8 | 53.9% | -314.9% | -53.6% | — |
| BEAM | $2.82B | -34.2 | 120.0% | -57.2% | -7.0% | — |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados 17
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $264M | $164M | $1M | · | · | · | · | $0 | $0 | $0 | $0 | $0 | |
| Cost of Revenue | $173M | $93M | $1M | · | · | · | · | · | · | · | · | · | |
| R&D Expense | $300M | $276M | $333M | $295M | $259M | $202M | $166M | $100M | $72M | $27M | $15M | $4M | |
| SG&A Expense | $152M | $152M | $106M | $104M | $84M | $60M | $41M | $28M | $21M | $27M | $12M | $8M | |
| Operating Expenses | $667M | $559M | $462M | $399M | $343M | $262M | $207M | $128M | $93M | $54M | $28M | $12M | |
| Operating Income | $-403M | $-395M | $-461M | $-399M | $-343M | $-262M | $-207M | $-128M | $-93M | $-54M | $-28M | $-12M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | $-5.7K | |
| Interest Income | $10M | $20M | $13M | $3M | $451.0K | $2M | $9M | $5M | $813.0K | $745.0K | $200.0K | $6.0K | |
| Other Non-op | · | · | · | · | · | · | · | · | · | · | $200.0K | $6.0K | |
| Pretax Income | $-393M | $-375M | $-448M | $-396M | $-342M | · | · | · | · | · | · | · | |
| Income Tax | $-2M | $-3M | $-3M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-391M | $-372M | $-444M | $-396M | $-342M | $-260M | $-198M | $-124M | $-92M | $-53M | $-28M | $-12M | |
| EPS (Basic) | $-1.09 | $-1.28 | $-1.89 | $-2.49 | $-2.23 | $-1.88 | $-1.59 | · | · | · | · | · | |
| EPS (Diluted) | $-1.09 | $-1.28 | $-1.89 | $-2.49 | $-2.23 | $-1.88 | $-1.59 | · | · | · | · | · | |
| Shares (Basic) | 357,345 | 289,877 | 235,131 | 159,259 | 153,406 | 138,301 | 124,336 | · | · | · | · | · | |
| Shares (Diluted) | 357,345 | 289,877 | 235,131 | 159,259 | 153,406 | 138,301 | 124,336 | · | · | · | · | · | |
| EBITDA | $-390M | $-383M | $-449M | $-390M | $-340M | $-261M | $-206M | $-128M | $-93M | $-54M | $-28M | · |
Balanço Patrimonial 28
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $163M | $116M | $115M | $232M | $78M | $67M | $14M | $82M | $145M | $107M | $34M | $45M | |
| Short-term Investments | $134M | $208M | $165M | $240M | $426M | $562M | $293M | $386M | $0 | $60M | $70M | $0 | |
| Receivables | $82M | $69M | $151.0K | · | · | · | · | · | · | · | · | · | |
| Inventory | $52M | $52M | $10M | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $12M | $12M | $17M | $7M | $4M | $7M | $9M | $7M | $4M | $3M | $277.0K | $66.0K | |
| Current Assets | $443M | $457M | $308M | $479M | $508M | $636M | $316M | $475M | $149M | $170M | $104M | $45M | |
| PP&E (Net) | $131M | $109M | $114M | $105M | $101M | $59M | $9M | $3M | $2M | $2M | $2M | $2M | |
| PP&E (Gross) | $180M | $145M | $142M | $122M | $110M | $65M | $13M | $7M | $5M | $4M | $3M | $2M | |
| Accum. Depreciation | $49M | $36M | $28M | $17M | $9M | $6M | $4M | $4M | $3M | $2M | $1M | $104.0K | |
| Intangibles | $279M | $282M | $229M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $8M | $369.0K | $270.0K | $189.0K | $2M | $13M | $3M | $3M | $4M | $0 | · | · | |
| Total Assets | $913M | $910M | $780M | $664M | $777M | $768M | $345M | $481M | $155M | $172M | $106M | $47M | |
| Accounts Payable | $22M | $28M | $33M | $27M | $27M | $14M | $16M | $3M | $1M | $863.0K | $958.0K | $1M | |
| Accrued Liabilities | $111M | $82M | $69M | $52M | $57M | $35M | $16M | $12M | $8M | $4M | $672.0K | $328.0K | |
| Short-term Debt | $1M | · | · | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $138M | $122M | $110M | $91M | $89M | $55M | $39M | $14M | $10M | $5M | $2M | $2M | |
| Capital Leases | $44M | $44M | $67M | $72M | $65M | $45M | $4M | $0 | · | · | · | · | |
| Deferred Tax | $32M | $32M | $17M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | $12M | $2M | $230.0K | · | · | · | · | |
| Total Liabilities | $215M | $200M | $196M | $164M | $156M | $112M | $46M | $15M | $10M | · | · | · | |
| Total Debt | $1M | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $17.0K | $13.0K | $11.0K | $8.0K | $7.0K | $6.0K | $5.0K | $5.0K | $3.0K | $3.0K | $2.0K | $2.0K | |
| Paid-in Capital | $3.46B | $3.10B | $2.59B | $2.07B | $1.79B | $1.49B | $869M | $839M | $395M | $324M | $208M | $121M | |
| Retained Earnings | $-2.78B | $-2.38B | $-2.01B | $-1.57B | $-1.17B | $-830M | $-571M | $-373M | $-249M | $-157M | $-104M | $-77M | |
| AOCI | $16M | $-1M | $3M | $-902.0K | $-601.0K | $19.0K | $220.0K | $-42.0K | $0 | $29.0K | $48.0K | $0 | |
| Stockholders' Equity | $699M | $710M | $585M | $500M | $622M | $656M | $299M | $466M | $145M | $167M | $104M | $45M | |
| Liabilities + Equity | $913M | $910M | $780M | $664M | $777M | $768M | $345M | $481M | $155M | $172M | $106M | $47M | |
| Shares Outstanding | 411,938,061 | 305,252,194 | 256,135,715 | 187,812,072 | 157,004,742 | 147,874,917 | 126,411,808 | 123,415,576 | 73,164,914 | 62,248,074 | 48,547,720 | 33,750,188 |
Fluxo de Caixa 17
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $13M | $11M | $12M | $9M | $3M | $1M | $1M | $956.0K | $952.0K | $978.0K | $999.0K | $88.0K | |
| Stock-based Comp | $62M | $110M | $63M | $84M | $70M | $41M | $24M | $20M | $12M | $19M | $9M | $4M | |
| Deferred Tax | $-2M | $-3M | $-3M | · | · | · | · | · | · | · | · | · | |
| Amort. of Intangibles | $23M | $26M | $10M | $0 | · | · | · | · | · | · | · | · | |
| Restructuring | $5M | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | $16M | $-100M | $12M | $10M | $41M | $12M | $13M | · | · | · | · | · | |
| Operating Cash Flow | $-302M | $-353M | $-362M | $-293M | $-228M | $-205M | $-159M | $-101M | $-79M | $-33M | $-18M | $-9M | |
| CapEx | $34M | $11M | $22M | $20M | $38M | $47M | $7M | $1M | $1M | $2M | $1M | $2M | |
| Investing Cash Flow | $47M | $-96M | $-155M | $256M | $132.0K | $-318M | $90M | $-386M | $59M | $9M | $-71M | · | |
| Debt Issued | · | · | · | · | $1M | · | · | · | · | · | · | · | |
| Net Debt Issued | · | · | · | · | $1M | · | · | · | · | · | · | · | |
| Stock Issued | $306M | $397M | $463M | $190M | $203M | $567M | · | $399M | $54M | $96M | $68M | $32M | |
| Net Stock Activity | $306M | $397M | $463M | $190M | $203M | $567M | · | $399M | $54M | $96M | $68M | · | |
| Financing Cash Flow | $301M | $391M | $463M | $190M | $239M | $576M | $6M | $424M | $59M | $97M | $78M | · | |
| Net Change in Cash | $47M | $-59M | $-57M | $154M | $11M | · | · | $-63M | $39M | $73M | $-11M | $25M | |
| Taxes Paid | $0 | $0 | $0 | · | · | · | · | $0 | $0 | $0 | $0 | $0 | |
| Free Cash Flow | $-336M | $-364M | $-384M | $-313M | $-266M | $-252M | $-166M | $-102M | $-80M | $-34M | $-20M | · |
Lucratividade 7
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -153.1% | -240.9% | -38735.0% | · | · | · | · | · | · | · | · | · | |
| Net Margin | -148.4% | -226.8% | -37345.4% | · | · | · | · | · | · | · | · | · | |
| Pretax Margin | -149.2% | -228.6% | -37638.0% | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -148.2% | -233.6% | -37762.1% | · | · | · | · | · | · | · | · | · | |
| ROA | -42.9% | -44.0% | -61.5% | -54.9% | -44.3% | -46.6% | -47.9% | -38.9% | -56.3% | -38.1% | -36.4% | · | |
| ROE | -56.0% | -50.2% | -70.6% | -88.6% | -51.9% | -37.9% | -60.4% | -34.3% | -58.9% | -39.0% | -37.2% | · | |
| ROIC | -57.4% | -55.2% | -78.2% | · | · | · | · | · | · | · | · | · |
Liquidez e Solvência 3
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.2 | 3.7 | 2.8 | 5.2 | 5.7 | 11.6 | 8.1 | 33.0 | 15.1 | 34.1 | 63.8 | · | |
| Quick Ratio | 2.7 | 3.2 | 2.5 | 5.2 | 5.7 | 11.5 | 7.9 | 32.5 | 14.7 | 33.5 | 51.4 | · | |
| Debt / Equity | 0.0 | · | · | · | · | · | · | · | · | · | · | · |
Eficiência 3
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.2 | 0.0 | · | · | · | · | 0.0 | 0.0 | 0.0 | 0.0 | · | |
| Inventory Turnover | 3.4 | 4.0 | 2.1 | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 3.5 | 4.7 | 15.7 | · | · | · | · | · | · | · | · | · |
Taxas de Crescimento 1
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 60.6% | 13699.0% | · | · | · | · | · | · | · | · | · | · |
Avaliação (TTM) 14
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $264M | $164M | $1M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income TTM | $-391M | $-372M | $-444M | $-396M | $-342M | $-260M | $-198M | $-124M | $-92M | $-53M | $-28M | $-12M | |
| Market Cap | $1.12B | $2.26B | $2.08B | $1.20B | $3.00B | $6.81B | $3.50B | $1.09B | $585M | $433M | $375M | · | |
| Enterprise Value | $829M | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -2.5 | -5.8 | -4.3 | -2.6 | -8.6 | -24.7 | -17.4 | · | · | · | · | · | |
| P/S | 4.3 | 13.8 | 1751.4 | · | · | · | · | · | · | · | · | · | |
| P/B | 1.6 | 3.2 | 3.6 | 2.4 | 4.8 | 10.4 | 11.7 | 2.3 | 4.0 | 2.6 | 3.6 | · | |
| P / Tangible Book | 2.7 | 5.3 | 5.9 | 2.4 | 4.8 | 10.4 | · | · | · | · | · | · | |
| P / Cash Flow | -3.7 | -6.4 | -5.8 | -4.1 | -13.1 | -33.2 | -22.0 | -10.8 | -7.4 | -13.2 | -20.4 | · | |
| P / FCF | -3.3 | -6.2 | -5.4 | -3.8 | -11.3 | -27.1 | -21.1 | -10.7 | -7.3 | -12.7 | -19.2 | · | |
| EV / EBITDA | -2.1 | · | · | · | · | · | · | · | · | · | · | · | |
| EV / FCF | -2.5 | · | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | 3.1 | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -39.9% | -17.3% | -23.2% | -39.0% | -11.7% | -4.0% | -5.7% | · | · | · | · | · |
Demonstração de Resultados 15
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $99M | $71M | $87M | $67M | $60M | $49M | $74M | $59M | $31M | $715.0K | $482.0K | $469.0K | $238.0K | · | · | · | |
| Cost of Revenue | $44M | $42M | $28M | $38M | $49M | $43M | $23M | $32M | $31M | $7M | $-5M | $4M | $2M | · | · | · | |
| R&D Expense | $59M | $62M | $69M | $75M | $78M | $76M | $67M | $67M | $62M | $80M | $77M | $88M | $86M | $83M | $81M | $73M | |
| SG&A Expense | $39M | $39M | $36M | $35M | $38M | $44M | $42M | $39M | $40M | $31M | $29M | $27M | $22M | $28M | $26M | $28M | |
| Operating Expenses | $151M | $152M | $160M | $162M | $174M | $171M | $160M | $148M | $133M | $118M | $122M | $119M | $110M | $111M | $107M | $100M | |
| Operating Income | $-52M | $-81M | $-73M | $-95M | $-114M | $-121M | $-87M | $-89M | $-102M | $-118M | $-121M | $-118M | $-110M | $-111M | $-107M | $-100M | |
| Interest Income | $3M | $1M | $2M | $1M | $4M | $3M | $10M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $777.0K | |
| Pretax Income | $-49M | $-80M | $-72M | $-94M | $-110M | $-118M | $-77M | $-85M | $-99M | $-114M | $-118M | $-115M | $-107M | $-107M | $-105M | $-100M | |
| Income Tax | $-1M | $-665.0K | $184.0K | $-2M | $2M | $-2M | $2M | $-2M | $-1M | $-1M | $-2M | $-1M | $-477.0K | $0 | · | · | |
| Net Income | $-47M | $-79M | $-72M | $-91M | $-112M | $-116M | $-79M | $-84M | $-97M | $-113M | $-116M | $-114M | $-107M | $-107M | $-105M | $-100M | |
| EPS (Basic) | $-0.11 | $-0.19 | $-0.15 | $-0.25 | $-0.33 | $-0.36 | $-0.24 | $-0.28 | $-0.34 | $-0.42 | $-0.46 | $-0.46 | $-0.47 | $-0.50 | $-0.65 | $-0.63 | |
| EPS (Diluted) | $-0.11 | $-0.19 | · | · | $-0.33 | $-0.36 | $-0.24 | $-0.28 | $-0.34 | $-0.42 | $-0.46 | $-0.46 | $-0.47 | $-0.50 | $-0.65 | $-0.63 | |
| Shares (Basic) | 450,189 | 418,511 | -664,071 | 364,037 | 334,511 | 322,868 | -564,429 | 303,269 | 284,817 | 266,220 | -213,929,167 | 245,817 | 224,481 | 213,694,000 | -472,044,741 | 157,817,000 | |
| Shares (Diluted) | 450,189 | 418,511 | · | · | 334,511 | 322,868 | -564,429 | 303,269 | 284,817 | 266,220 | -213,929,167 | 245,817 | 224,481 | 213,694,000 | -472,044,741 | 157,817,000 | |
| EBITDA | $-52M | $-78M | · | $-95M | $-110M | $-118M | · | $-86M | $-99M | $-115M | · | $-115M | $-107M | $-108M | · | $-100M |
Balanço Patrimonial 27
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $111M | $197M | $163M | $158M | $132M | $172M | $116M | $164M | $229M | $134M | $115M | $268M | $230M | $543M | $232M | $118M | |
| Short-term Investments | $187M | $117M | $134M | $143M | $169M | $188M | $208M | $233M | $184M | $222M | · | $94M | $21M | $83M | · | $242M | |
| Receivables | $102M | $82M | $82M | $67M | $60M | $71M | $69M | $56M | $32M | $234.0K | · | · | $33.0K | · | · | · | |
| Inventory | $56M | $58M | $52M | $52M | $50M | $66M | $52M | $39M | $28M | $18M | · | $9M | $10M | · | · | · | |
| Prepaid Expense | $9M | $13M | $12M | $10M | $12M | $16M | $12M | $7M | $10M | $11M | · | $12M | $14M | $11M | · | $10M | |
| Current Assets | $464M | $467M | $443M | $429M | $422M | $513M | $457M | $499M | $482M | $386M | · | $383M | $275M | $638M | · | $370M | |
| PP&E (Net) | $131M | $131M | $131M | $127M | $122M | $112M | $109M | $113M | $111M | $112M | · | $113M | $113M | $110M | · | $101M | |
| PP&E (Gross) | $188M | $184M | $180M | $172M | $165M | $150M | $145M | $149M | $145M | $143M | · | $138M | $135M | $129M | · | $115M | |
| Accum. Depreciation | $56M | $52M | $49M | $45M | $42M | $39M | $36M | $37M | $34M | $31M | · | $25M | $22M | $19M | · | $14M | |
| Intangibles | $264M | $269M | $279M | $285M | $296M | $285M | $282M | $307M | $295M | $294M | · | $224M | $236M | · | · | · | |
| Other Non-current Assets | $6M | $8M | $8M | $9M | $10M | $426.0K | $369.0K | $280.0K | $327.0K | $259.0K | · | $282.0K | $294.0K | $202.0K | · | $596.0K | |
| Total Assets | $916M | $926M | $913M | $905M | $907M | $967M | $910M | $991M | $964M | $870M | · | $852M | $757M | $825M | · | $546M | |
| Accounts Payable | $26M | $37M | $22M | $31M | $32M | $28M | $28M | $32M | $20M | $26M | · | $19M | $31M | $32M | · | $24M | |
| Accrued Liabilities | $78M | $88M | $111M | $87M | $89M | $85M | $82M | $75M | $62M | $46M | · | $61M | $47M | $43M | · | $48M | |
| Short-term Debt | · | $1M | $1M | $1M | $1M | $1M | · | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $107M | $129M | $138M | $126M | $129M | $123M | $122M | $118M | $94M | $83M | · | $91M | $89M | $87M | · | $79M | |
| Capital Leases | $43M | $44M | $44M | $45M | $45M | $44M | $44M | $66M | $69M | $72M | · | $68M | $69M | $70M | · | $72M | |
| Deferred Tax | $29M | $31M | $32M | $32M | $35M | $32M | $32M | $32M | $32M | $33M | · | $18M | $20M | · | · | · | |
| Total Liabilities | $179M | $204M | $215M | $203M | $209M | $199M | $200M | $218M | $196M | $190M | · | $178M | $179M | $158M | · | $152M | |
| Total Debt | · | $1M | · | $1M | $1M | $1M | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $19.0K | $18.0K | $17.0K | $16.0K | $14.0K | $14.0K | $13.0K | $13.0K | $12.0K | $12.0K | · | $11.0K | $9.0K | $9.0K | · | $7.0K | |
| Paid-in Capital | $3.62B | $3.56B | $3.46B | $3.39B | $3.29B | $3.26B | $3.10B | $3.06B | $2.99B | $2.81B | · | $2.58B | $2.36B | $2.34B | · | $1.86B | |
| Retained Earnings | $-2.90B | $-2.85B | $-2.78B | $-2.70B | $-2.61B | $-2.50B | $-2.38B | $-2.31B | $-2.22B | $-2.13B | · | $-1.90B | $-1.78B | $-1.68B | · | $-1.46B | |
| AOCI | $13M | $13M | $16M | $16M | $21M | $6M | $-1M | $16M | $526.0K | $116.0K | · | $-9M | $325.0K | $-126.0K | · | $-2M | |
| Stockholders' Equity | $736M | $722M | $699M | $702M | $698M | $768M | $710M | $773M | $769M | $680M | $585M | $674M | $579M | $667M | $500M | $394M | |
| Liabilities + Equity | $916M | $926M | $913M | $905M | $907M | $967M | $910M | $991M | $964M | $870M | · | $852M | $757M | $825M | · | $546M | |
| Shares Outstanding | 452,971,016 | 438,106,537 | 411,938,061 | 385,461,728 | 341,919,364 | 333,934,387 | 305,252,194 | 304,620,470 | 297,305,999 | 279,756,339 | · | 255,833,679 | 224,688,434 | 224,358,979 | · | 157,840,581 |
Fluxo de Caixa 15
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4M | $3M | $4M | $3M | $3M | $3M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | |
| Stock-based Comp | $12M | $11M | $12M | $12M | $15M | $23M | $31M | $31M | $30M | $17M | $14M | $16M | $17M | $16M | $20M | $20M | |
| Deferred Tax | $-1M | $-665.0K | $184.0K | $-2M | $2M | $-2M | $2M | $-2M | $-1M | $-1M | $-2M | $-1M | $-477.0K | $0 | · | $0 | |
| Amort. of Intangibles | $6M | $6M | $6M | $6M | $6M | $5M | $11M | $6M | $6M | $5M | $4M | $4M | $2M | $0 | · | $0 | |
| Restructuring | · | · | $0 | $5M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $-6M | · | · | · | $-11M | · | · | · | $-28M | · | · | · | $-11M | · | · | |
| Operating Cash Flow | $-61M | $-72M | $-53M | $-79M | $-67M | $-104M | $-73M | $-59M | $-98M | $-122M | $-84M | $-84M | $-94M | $-100M | $-78M | $-64M | |
| CapEx | $5M | $7M | $9M | $11M | $7M | $6M | $4M | $2M | $442.0K | $4M | $4M | $4M | $10M | $6M | $3M | $1M | |
| Investing Cash Flow | $-74M | $11M | $775.0K | $17M | $14M | $16M | $24M | $-49M | $40M | $-112M | $-73M | $-79M | $-157M | $153M | $461.0K | $74M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Stock Issued | $50M | $99M | $56M | $89M | $13M | $149M | $0 | $48M | $152M | $198M | $1.0K | $203M | $0 | $260M | $190M | $0 | |
| Net Stock Activity | · | $99M | · | · | · | $149M | · | · | · | $198M | · | · | · | $260M | · | · | |
| Financing Cash Flow | $49M | $94M | $56M | $88M | $13M | $143M | $2M | $42M | $153M | $194M | $962.0K | $203M | $1M | $258M | $191M | $225.0K | |
| Net Change in Cash | $-86M | $33M | $5M | $26M | $-40M | $56M | $-48M | $-65M | $94M | $-41M | $-153M | $38M | $-253M | $312M | $113M | $10M | |
| Free Cash Flow | · | $-79M | · | · | · | $-110M | · | · | · | $-126M | · | · | · | $-105M | · | · |
Lucratividade 7
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -52.3% | -113.5% | · | -140.7% | -189.8% | -245.8% | · | -152.1% | -327.6% | -16464.6% | · | -25236.9% | -46254.6% | · | · | · | |
| Net Margin | -47.6% | -110.7% | · | -135.3% | -186.2% | -235.5% | · | -142.7% | -312.2% | -15800.8% | · | -24255.9% | -44759.7% | · | · | · | |
| Pretax Margin | -49.0% | -111.6% | · | -138.8% | -182.9% | -239.2% | · | -145.3% | -316.8% | -15997.8% | · | -24520.9% | -44960.1% | · | · | · | |
| EBITDA Margin | -52.3% | -109.5% | · | -140.7% | -184.1% | -240.1% | · | -147.0% | -318.0% | -16048.1% | · | -24618.5% | -45036.1% | · | · | · | |
| ROA | -5.2% | -8.3% | · | -9.6% | -11.9% | -12.7% | · | -9.1% | -11.3% | -13.3% | · | -16.3% | -15.6% | -14.1% | · | -14.5% | |
| ROE | -6.6% | -10.6% | · | -12.4% | -15.2% | -16.1% | · | -11.5% | -14.4% | -16.8% | · | -21.3% | -20.3% | -17.6% | · | -18.2% | |
| ROIC | -6.9% | -11.1% | · | -13.2% | -16.6% | -15.5% | · | -11.3% | -13.1% | -17.1% | · | -17.4% | -18.9% | · | · | · |
Liquidez e Solvência 3
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.3 | 3.6 | · | 3.4 | 3.3 | 4.2 | · | 4.2 | 5.2 | 4.6 | · | 4.2 | 3.1 | 7.3 | · | 4.7 | |
| Quick Ratio | 3.7 | 3.1 | · | 2.9 | 2.8 | 3.5 | · | 3.8 | 4.7 | 4.3 | · | 4.0 | 2.8 | 7.2 | · | 4.5 | |
| Debt / Equity | · | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | · | · | · | · | · | · | · | · |
Eficiência 3
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · | |
| Inventory Turnover | 0.8 | 0.7 | · | 0.9 | 1.5 | 1.2 | · | 1.7 | 1.7 | 0.8 | · | 0.9 | 0.4 | · | · | · | |
| Receivables Turnover | 1.2 | 0.9 | · | 1.1 | 1.3 | 1.4 | · | 2.1 | 2.0 | 6.1 | · | · | 14.4 | · | · | · |
Avaliação (TTM) 14
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $298M | $248M | · | $235M | $199M | $140M | · | $91M | $33M | · | · | · | · | $0 | · | $0 | |
| Net Income TTM | $-329M | $-398M | · | $-403M | $-408M | $-410M | · | $-407M | $-430M | $-441M | · | $-427M | $-413M | $-398M | · | $-377M | |
| Market Cap | $1.88B | $1.54B | · | $836M | $588M | $1.11B | · | $2.86B | $2.38B | $4.15B | · | $1.16B | $1.58B | $1.37B | · | $1.51B | |
| Enterprise Value | · | $1.23B | · | $537M | $288M | $753M | · | · | · | · | · | · | · | · | · | · | |
| P/E | · | · | · | -1.7 | -1.3 | -2.4 | · | -6.3 | -4.7 | -8.0 | · | -2.2 | -3.2 | -2.6 | · | -4.0 | |
| P/S | 6.3 | 6.2 | · | 3.6 | 3.0 | 8.0 | · | 31.5 | 73.3 | · | · | · | · | · | · | · | |
| P/B | 2.6 | 2.1 | · | 1.2 | 0.8 | 1.4 | · | 3.7 | 3.1 | 6.1 | · | 1.7 | 2.7 | 2.1 | · | 3.8 | |
| P / Tangible Book | 4.0 | 3.4 | · | 2.0 | 1.5 | 2.3 | · | 6.1 | 5.0 | 10.7 | · | 2.6 | 4.6 | 2.1 | · | 3.8 | |
| P / Cash Flow | · | -21.3 | · | · | · | -10.7 | · | · | · | -33.9 | · | · | · | -13.7 | · | · | |
| P / FCF | · | -19.5 | · | · | · | -10.1 | · | · | · | -32.8 | · | · | · | -13.0 | · | · | |
| EV / EBITDA | · | -15.7 | · | -5.7 | -2.6 | -6.4 | · | · | · | · | · | · | · | · | · | · | |
| EV / FCF | · | -15.6 | · | · | · | -6.9 | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | · | 4.9 | · | 2.3 | 1.4 | 5.4 | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | · | · | · | -60.4% | -76.2% | -42.0% | · | -16.0% | -21.1% | -12.5% | · | -45.3% | -31.7% | -38.3% | · | -24.9% |
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
Demonstração de Resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Receita | $264M | $164M | $1M | — | — |
| Margem Operacional % | -153.1% | -240.9% | -38735.0% | — | — |
| Lucro líquido | $-391M | $-372M | $-444M | $-396M | $-342M |
| EPS Diluído | $-1.09 | $-1.28 | $-1.89 | $-2.49 | $-2.23 |
Balanço Patrimonial
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dívida / Patrimônio Líquido | 0.0 | — | — | — | — |
| Índice de liquidez corrente | 3.2 | 3.7 | 2.8 | 5.2 | 5.7 |
| Índice de Liquidez Seca | 2.7 | 3.2 | 2.5 | 5.2 | 5.7 |
Fluxo de Caixa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $-336M | $-364M | $-384M | $-313M | $-266M |
Últimas notícias Notícias recentes mencionando esta empresa
- Iovance Biotherapeutics (IOVA) dispara 43% com resultados sólidos no 2º trimestre. O que vem a seguir
- Is Iovance Biotherapeutics, Inc. (IOVA) One of the Most Shorted Small-Cap Stocks to Buy Now?
- Chardan Corta Meta de Preço de Iovance (IOVA), Mantém Recomendação Comprar
- Iovance Biotherapeutics Destaques da Chamada de Resultados do 1º Trimestre
- O Sentimento dos Analistas Permanece Forte na Iovance Biotherapeutics (IOVA) em Meio ao Lançamento nos EUA do Medicamento para Melanoma, Amtagvi
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Investidores institucionais (13F) 316 declarantes · $915.1M total · Em 30 de Junho de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 49 (-15 vs trimestre anterior) | 35 (0 vs trimestre anterior) | 124 (+7 vs trimestre anterior) | 62 (-4 vs trimestre anterior) | +44.5M |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| MHR FUND MANAGEMENT LLC | $120.503.148 | 28.967.103 | 13,17% | Ações |
| STATE STREET CORP | $101.829.595 | 24.478.268 | 11,13% | Ações |
| TWO SIGMA INVESTMENTS, LP | $79.084.500 | 19.010.697 | 8,64% | Ações |
| VANGUARD CAPITAL MANAGEMENT LLC | $75.729.672 | 18.204.248 | 8,28% | Ações |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $59.858.236 | 14.388.999 | 6,54% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $36.971.836 | 8.885.825 | 4,04% | Ações |
| MILLENNIUM MANAGEMENT LLC | $35.467.823 | 8.525.919 | 3,88% | Ações |
| DIMENSIONAL FUND ADVISORS LP | $24.866.629 | 5.977.555 | 2,72% | Ações |
| Palo Alto Investors LP | $22.032.229 | 5.296.209 | 2,41% | Ações |
| BANK OF AMERICA CORP /DE/ | $19.240.719 | 4.625.173 | 2,10% | Ações |
| JUPITER ASSET MANAGEMENT LTD | $18.865.933 | 4.535.080 | 2,06% | Ações |
| JANE STREET GROUP, LLC | $17.758.903 | 4.268.967 | 1,94% | Ações |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $13.393.769 | 3.219.656 | 1,46% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $11.097.216 | 2.667.600 | 1,21% | Opção de compra |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $11.052.038 | 2.656.740 | 1,21% | Ações |
| GOLDMAN SACHS GROUP INC | $10.683.579 | 2.568.168 | 1,17% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $10.578.372 | 2.542.878 | 1,16% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $9.953.632 | 2.392.700 | 1,09% | Opção de venda |
| D. E. Shaw & Co., Inc. | $8.915.437 | 2.143.134 | 0,97% | Ações |
| CITADEL ADVISORS LLC | $8.756.758 | 2.104.990 | 0,96% | Ações |
| Long Focus Capital Management, LLC | $8.736.000 | 2.100.000 | 0,95% | Ações |
| Orion Investment Co | $8.624.520 | 2.073.202 | 0,94% | Ações |
| TWO SIGMA ADVISERS, LP | $8.230.950 | 3.015.000 | 0,90% | Ações |
| Xcelsior Advisor Partners LLC | $7.421.124 | 1.783.924 | 0,81% | Ações |
| Rhenman & Partners Asset Management AB | $7.094.160 | 1.705.327 | 0,78% | Ações |
| Knott David M Jr | $6.656.000 | 1.600.000 | 0,73% | Ações |
| RICE HALL JAMES & ASSOCIATES, LLC | $6.405.734 | 1.539.840 | 0,70% | Ações |
| B Group, Inc. | $6.240.000 | 1.500.000 | 0,68% | Ações |
| Invenomic Capital Management LP | $6.167.595 | 1.482.595 | 0,67% | Ações |
| WELLS FARGO & COMPANY/MN | $5.994.285 | 1.440.934 | 0,66% | Ações |
| VANGUARD GROUP INC | $5.760.305 | 2.110.002 | 0,63% | Ações |
| Woodline Partners LP | $5.671.020 | 1.363.226 | 0,62% | Ações |
| FMR LLC | $5.629.570 | 1.353.262 | 0,62% | Ações |
| JPMORGAN CHASE & CO | $4.919.364 | 1.168.495 | 0,54% | Ações |
| Mirador Capital Partners LP | $4.493.998 | 1.080.288 | 0,49% | Ações |
| Susquehanna Portfolio Strategies, LLC | $4.391.217 | 1.055.581 | 0,48% | Ações |
| SECTOR GAMMA AS | $4.028.819 | 968.466 | 0,44% | Ações |
| CITIGROUP INC | $3.574.126 | 859.165 | 0,39% | Ações |
| CITADEL ADVISORS LLC | $3.385.824 | 813.900 | 0,37% | Opção de compra |
| BlackRock, Inc. | $3.047.371 | 732.541 | 0,33% | Ações |
| JANE STREET GROUP, LLC | $3.037.216 | 730.100 | 0,33% | Opção de compra |
| CITADEL ADVISORS LLC | $2.996.864 | 720.400 | 0,33% | Opção de venda |
| Swiss National Bank | $2.922.633 | 702.556 | 0,32% | Ações |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $2.862.637 | 688.134 | 0,31% | Ações |
| AMERICAN CENTURY COMPANIES INC | $2.848.240 | 684.673 | 0,31% | Ações |
| QVT Financial LP | $2.822.826 | 678.564 | 0,31% | Ações |
| LPL Financial LLC | $2.750.070 | 661.075 | 0,30% | Ações |
| 683 Capital Management, LLC | $2.680.288 | 644.300 | 0,29% | Opção de venda |
| RHUMBLINE ADVISERS | $2.471.712 | 594.164 | 0,27% | Ações |
| Mariner, LLC | $2.101.647 | 505.190 | 0,23% | Ações |
| ALGERT GLOBAL LLC | $1.975.746 | 474.939 | 0,22% | Ações |
| CM Management, LLC | $1.872.000 | 450.000 | 0,20% | Ações |
| Bank of New York Mellon Corp | $1.855.065 | 445.929 | 0,20% | Ações |
| Rafferty Asset Management, LLC | $1.675.981 | 402.880 | 0,18% | Ações |
| Raiffeisen Bank International AG | $1.599.800 | 380.000 | 0,17% | Ações |
| Cresset Asset Management, LLC | $1.596.550 | 383.786 | 0,17% | Ações |
| Balyasny Asset Management L.P. | $1.552.861 | 373.284 | 0,17% | Ações |
| CORSAIR CAPITAL MANAGEMENT, L.P. | $1.539.200 | 370.000 | 0,17% | Ações |
| ALLIANCEBERNSTEIN L.P. | $1.477.850 | 421.040 | 0,16% | Ações |
| JANE STREET GROUP, LLC | $1.436.032 | 345.200 | 0,16% | Opção de venda |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $1.420.778 | 404.780 | 0,16% | Ações |
| Squarepoint Ops LLC | $1.354.421 | 325.582 | 0,15% | Ações |
| Kennondale Capital Management LLC | $1.323.662 | 318.188 | 0,14% | Ações |
| TUDOR INVESTMENT CORP ET AL | $1.222.994 | 293.989 | 0,13% | Ações |
| IEQ CAPITAL, LLC | $1.218.722 | 292.962 | 0,13% | Ações |
| STATE OF WISCONSIN INVESTMENT BOARD | $1.186.078 | 285.115 | 0,13% | Ações |
| Virtus Investment Advisers, LLC | $1.185.683 | 285.020 | 0,13% | Ações |
| Creative Planning | $1.171.914 | 281.710 | 0,13% | Ações |
| Quadrature Capital Ltd | $1.160.378 | 278.937 | 0,13% | Ações |
| MORGAN STANLEY | $1.142.544 | 274.650 | 0,12% | Ações |
| ExodusPoint Capital Management, LP | $1.125.925 | 270.655 | 0,12% | Ações |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $1.090.532 | 262.147 | 0,12% | Ações |
| Man Group plc | $1.052.309 | 252.959 | 0,11% | Ações |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1.036.826 | 295.392 | 0,11% | Ações |
| VANGUARD ASSET MANAGEMENT, Ltd | $1.025.353 | 246.479 | 0,11% | Ações |
| TD Asset Management Inc | $1.019.416 | 245.052 | 0,11% | Ações |
| GROUP ONE TRADING LLC | $988.711 | 237.671 | 0,11% | Ações |
| MetLife Investment Management, LLC | $965.748 | 232.151 | 0,11% | Ações |
| UBS Group AG | $952.890 | 229.060 | 0,10% | Ações |
| Baird Financial Group, Inc. | $924.934 | 222.340 | 0,10% | Ações |
| Walleye Capital LLC | $923.104 | 221.900 | 0,10% | Opção de compra |
| Vanguard Global Advisers, LLC | $900.228 | 216.401 | 0,10% | Ações |
| PROFUND ADVISORS LLC | $849.530 | 204.214 | 0,09% | Ações |
| Parametrica Management Ltd | $814.852 | 195.878 | 0,09% | Ações |
| Engineers Gate Manager LP | $790.546 | 190.035 | 0,09% | Ações |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $762.349 | 183.257 | 0,08% | Ações |
| Invesco Ltd. | $657.292 | 158.003 | 0,07% | Ações |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $646.872 | 155.498 | 0,07% | Ações |
| OSAIC HOLDINGS, INC. | $635.207 | 152.695 | 0,07% | Ações |
| Intellectus Partners, LLC | $631.677 | 151.846 | 0,07% | Ações |
| Leonteq Securities AG | $624.000 | 150.000 | 0,07% | Ações |
| Soleus Capital Management, L.P. | $624.000 | 150.000 | 0,07% | Ações |
| ADAR1 Capital Management, LLC | $607.734 | 146.090 | 0,07% | Ações |
| Headlands Technologies LLC | $577.570 | 138.839 | 0,06% | Ações |
| Sugar Maple Asset Management, LLC | $561.600 | 135.000 | 0,06% | Ações |
| PORTLAND INVESTMENT COUNSEL INC. | $540.800 | 130.000 | 0,06% | Ações |
| SIMPLEX TRADING, LLC | $524.605 | 126.107 | 0,06% | Ações |
| JANUS HENDERSON GROUP PLC | $497.977 | 141.672 | 0,05% | Ações |
| Police & Firemen's Retirement System of New Jersey | $488.292 | 117.378 | 0,05% | Ações |
| BARCLAYS PLC | $482.759 | 116.048 | 0,05% | Ações |
Executivos da empresa 37 insiders · 9 diretores · 14 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Frederick G Vogt | Interim CEO & General Counsel | 5 de Junho de 2026 M | 562.492 | 0 | 0 | $0 |
| Maria Fardis | President and CEO | 4 de Janeiro de 2021 A | 298.786 | 0 | 0 | $0 |
| Paul Kessler | Chair,CEO, Pres., Pr.Acctg | 24 de Julho de 2013 A | 15.693.215 | 0 | 0 | $0 |
| Jean-Marc Bellemin | Chief Financial Officer | 2 de Junho de 2025 M | 60.529 | 0 | 0 | $0 |
| Timothy E Morris | Chief Financial Officer | 4 de Março de 2019 A | — | 0 | 0 | $0 |
| Igor Bilinsky | Chief Operating Officer | 5 de Junho de 2026 M | 133.920 | 0 | 0 | $0 |
| Raj K. Puri | Chief Regulatory Officer | 16 de Junho de 2026 A | 248.114 | 0 | 0 | $0 |
| Finckenstein Friedrich Graf | Chief Medical Officer | 5 de Junho de 2026 M | 140.111 | 0 | 0 | $0 |
| Michael Swartzburg | Vice President, Finance (PAO) | 4 de Janeiro de 2021 A | — | 0 | 0 | $0 |
| Iain D. Dukes | Conselheiro | 16 de Junho de 2026 A | 54.000 | 0 | 0 | $0 |
| Athena Countouriotis | Conselheiro | 16 de Junho de 2026 A | — | 0 | 0 | $0 |
| Ryan D Maynard | Conselheiro | 16 de Junho de 2026 A | 7.500 | 0 | 0 | $0 |
| Michael Weiser | Conselheiro | 16 de Junho de 2026 A | 112.632 | 0 | 0 | $0 |
| Wendy L Yarno | Conselheiro | 13 de Junho de 2025 A | — | 0 | 0 | $0 |
| Wayne P. Rothbaum | Conselheiro | 1 de Março de 2024 A | 28.067.333 | 0 | 0 | $0 |
| Merrill A Mcpeak | Conselheiro | 1 de Março de 2024 A | 320.150 | 0 | 0 | $0 |
| Wendy L Dixon | Conselheiro | 10 de Junho de 2022 A | — | 0 | 0 | $0 |
| Ayer Capital Management, LP | Conselheiro | 22 de Maio de 2013 C | 560.401.150 | 0 | 0 | $0 |
| Martin Schroeder | Conselheiro | 22 de Agosto de 2011 P | 1.000.000 | 0 | 0 | $0 |
| Mark J Ahn | Conselheiro | 26 de Maio de 2010 A | — | 0 | 0 | $0 |
| Bristol Investment Fund, Ltd. | Detentor de 10% | 6 de Novembro de 2014 S | 3.867.863 | 0 | 0 | $0 |
| Hamilton Atlantic | Detentor de 10% | 31 de Março de 2010 J | 0 | 0 | 0 | $0 |
| Daniel Gordon Kirby | — | 10 de Agosto de 2026 M | 154.511 | 0 | 0 | $0 |
| Corleen M. Roche | — | 6 de Agosto de 2026 M | 28.757 | 0 | 0 | $0 |
| Jay Venkatesan | — | 1 de Junho de 2017 A | — | 0 | 0 | $0 |
| Sanford Hillsberg | — | 1 de Junho de 2017 A | 100.000 | 0 | 0 | $0 |
| Gregory T Schiffman | — | 14 de Novembro de 2016 A | — | 0 | 0 | $0 |
| Molly Henderson | — | 10 de Junho de 2016 A | — | 0 | 0 | $0 |
| Michael Lotze | — | 28 de Março de 2016 A | — | 0 | 0 | $0 |
| James G. Bender | — | 11 de Março de 2016 A | 88.726 | 0 | 0 | $0 |
| Elma Hawkins | — | 11 de Março de 2016 A | 176.567 | 0 | 0 | $0 |
| Steven A. Fischkoff | — | 4 de Fevereiro de 2016 A | — | 0 | 0 | $0 |
| Laszlo Radvanyi | — | 5 de Dezembro de 2014 A | 180.000 | 0 | 0 | $0 |
| Michael D Handelman | — | 5 de Dezembro de 2014 A | — | 0 | 0 | $0 |
| Manish Singh | — | 30 de Dezembro de 2013 A | 2.546.000 | 0 | 0 | $0 |
| Richard Mckilligan | — | 29 de Março de 2011 J | 1.220.016 | 0 | 0 | $0 |
| Robert T. Brooke | — | 25 de Março de 2011 J | 4.440.008 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Ativistas e proprietários de 5%+ 6 participações
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| Quogue Capital LLC, Wayne P. Rothbaum ×5 declarações | 19 de Março de 2024 | — | Declaração inicial | — | SEC |
| Pessoa de relato não divulgada | 11 de Fevereiro de 2015 | — | Declaração inicial | — | SEC |
| Bristol Investment Fund, Ltd., Bristol Capital, LLC ×4 declarações | 20 de Fevereiro de 2014 | — | Declaração inicial | — | SEC |
| Robert T. Brooke ×2 declarações | 12 de Maio de 2011 | — | Declaração inicial | — | SEC |
| Hamilton Atlantic | 5 de Novembro de 2010 | — | Declaração inicial | M&A / venda | SEC |
| Pessoa de relato não divulgada | 29 de Março de 2010 | — | Declaração inicial | M&A / venda | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Participação em ETFs Detido por 49 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| IDNA · iShares Trust | 2,65% | 841.830 SH | 8 de Agosto de 2026 | Diário |
| BBP · ETFis Series Trust I | 2,44% | 430.167 NS | 30 de Abril de 2026 | N-PORT |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,77% | 27.306 SH | 8 de Agosto de 2026 | Diário |
| CANC · Tema ETF Trust | 0,65% | 280.048 NS | 31 de Maio de 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,30% | 466.051 NS | 30 de Abril de 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,23% | 1.035.381 SH | 8 de Agosto de 2026 | Diário |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,19% | 24.302 SH | 8 de Agosto de 2026 | Diário |
| IBB · iShares Trust | 0,19% | 2.852.725 SH | 8 de Agosto de 2026 | Diário |
| IWN · iShares Trust | 0,16% | 3.686.426 SH | 8 de Agosto de 2026 | Diário |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,11% | 346.628 SH | 8 de Agosto de 2026 | Diário |
| GINN · Goldman Sachs ETF Trust | 0,09% | 45.126 NS | 31 de Maio de 2026 | N-PORT |
| TMFX · RBB Fund, Inc. | 0,09% | 6.714 NS | 31 de Maio de 2026 | N-PORT |
| BIB · ProShares Trust | 0,08% | 15.232 NS | 31 de Maio de 2026 | N-PORT |
| IWM · iShares Trust | 0,08% | 10.143.030 SH | 8 de Agosto de 2026 | Diário |
| ISCV · iShares Trust | 0,07% | 76.919 SH | 8 de Agosto de 2026 | Diário |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,07% | 452.513 NS | 31 de Maio de 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,05% | 261.797 SH | 8 de Agosto de 2026 | Diário |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,05% | 2.290.247 SH | 8 de Agosto de 2026 | Diário |
| TECB · iShares Trust | 0,05% | 38.134 SH | 8 de Agosto de 2026 | Diário |
| DFAS · Dimensional ETF Trust | 0,04% | 1.472.303 NS | 30 de Abril de 2026 | N-PORT |
| ITWO · ProShares Trust | 0,03% | 15.876 NS | 31 de Maio de 2026 | N-PORT |
| RSSL · Global X Funds | 0,03% | 146.249 NS | 30 de Abril de 2026 | N-PORT |
| ISCB · iShares Trust | 0,03% | 15.580 SH | 8 de Agosto de 2026 | Diário |
| SCHA · SCHWAB STRATEGIC TRUST | 0,03% | 1.615.534 NS | 31 de Maio de 2026 | N-PORT |
| UWM · ProShares Trust | 0,02% | 12.416 NS | 31 de Maio de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 4.303.944 SH | 8 de Agosto de 2026 | Diário |
| VBR · VANGUARD INDEX FUNDS | 0,02% | 3.089.380 SH | 8 de Agosto de 2026 | Diário |
| VHT · VANGUARD WORLD FUND | 0,02% | 1.053.780 SH | 8 de Agosto de 2026 | Diário |
| WSML · iShares Trust | 0,02% | 21.537 SH | 8 de Agosto de 2026 | Diário |
| TMFE · RBB Fund, Inc. | 0,02% | 3.704 NS | 31 de Maio de 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 140.923 NS | 30 de Abril de 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,02% | 18.065 NS | 30 de Abril de 2026 | N-PORT |
| URTY · ProShares Trust | 0,01% | 12.558 NS | 31 de Maio de 2026 | N-PORT |
| TILT · FlexShares Trust | 0,01% | 71.148 NS | 30 de Abril de 2026 | N-PORT |
| VB · VANGUARD INDEX FUNDS | 0,01% | 4.849.607 SH | 8 de Agosto de 2026 | Diário |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 12.045 NS | 31 de Maio de 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 315 NS | 31 de Maio de 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 44.207 NS | 30 de Abril de 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,00% | 125.344 NS | 31 de Maio de 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 146.278 NS | 30 de Abril de 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 482.457 NS | 30 de Abril de 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 510.986 SH | 8 de Agosto de 2026 | Diário |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,00% | 89.379 NS | 31 de Maio de 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 16.834 NS | 30 de Abril de 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 128.547 NS | 30 de Abril de 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 224.829 NS | 31 de Maio de 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 64.557 SH | 8 de Agosto de 2026 | Diário |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 13.489.795 SH | 8 de Agosto de 2026 | Diário |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 32.806 SH | 8 de Agosto de 2026 | Diário |